Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Gong, Xia  [Clear All Filters]
2022
Lam SMan, Li J, Sun H, Mao W, Liu Z, Zhao Q, Han C, Gong X, Jiang B, Chua GHuey, et al. Quantitative lipidomics and spatial MS-Imaging uncovered neurological and systemic lipid metabolic pathways underlying troglomorphic adaptations in cave-dwelling fish. Mol Biol Evol. 2022.
2020
Zhang X, Kuang G, Wan J, Jiang R, Ma L, Gong X, Liu X. Salidroside protects mice against CCl4-induced acute liver injury via down-regulating CYP2E1 expression and inhibiting NLRP3 inflammasome activation. Int Immunopharmacol. 2020;85:106662.
Lv J, Su Y, Song L, Gong X, Peng Y. Stem cell 'therapy' advertisements in China: Infodemic, regulations and recommendations. Cell Prolif. 2020:e12937.
2019
Jiang X, Kuang G, Gong X, Jiang R, Xie T, Tie H, Wu S, Wang T, Wan J, Wang B. Glycyrrhetinic acid pretreatment attenuates liver ischemia/reperfusion injury via inhibiting TLR4 signaling cascade in mice. Int Immunopharmacol. 2019;76:105870.
Li J, Hu L, Zhou T, Gong X, Jiang R, Li H, Kuang G, Wan J, Li H. Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling. Life Sci. 2019:116617.
2015
Chen X, Gong X, Jiang R, Wang B, Kuang G, Li K, Wan J. Resolvin D1 attenuates CCl4-induced acute liver injury involving up-regulation of HO-1 in mice. Immunopharmacol Immunotoxicol. 2015:1-7.
2014
Yin X, Gong X, Jiang R, Kuang G, Wang B, Zhang L, Xu G, Wan J. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice. Int Immunopharmacol. 2014.